| NCT ID | NCT05264337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vastra Gotaland Region |
| Condition | Urinary Bladder Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-03-14 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2022-03-14 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lymphedema of the extremities is common after lymph node surgery in treating several forms of cancer, e.g., breast cancer. However, very little is known of the occurrence of lymphedema of the lower extremities after urologic surgery with lymph node dissection. This project aims to describe the frequency and grade of lymphedema arising after urologic surgery, using the Lymphedema Quality of Life Questionnaire (LymQOL), Delfin MoistureMeter D, and lower limb volume measurements.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing urologic surgery with lymph node dissection Exclusion Criteria: * None
Contact & Investigator
Henrik Kjölhede, MD, PhD
PRINCIPAL INVESTIGATOR
Sahlgrenska University Hospital, Gothenburg University
Frequently Asked Questions
Who can join the NCT05264337 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary Bladder Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05264337 currently recruiting?
Yes, NCT05264337 is actively recruiting participants. Contact the research team at henrik.kjolhede@vgregion.se for enrollment information.
Where is the NCT05264337 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Örebro, Sweden.
Who is sponsoring the NCT05264337 clinical trial?
NCT05264337 is sponsored by Vastra Gotaland Region. The principal investigator is Henrik Kjölhede, MD, PhD at Sahlgrenska University Hospital, Gothenburg University. The trial plans to enroll 400 participants.